Accelerator™ Drug Development: Streamlining preclinical pathways for a faster transition to First-in-Human trials
Accelerator™ Drug Development: Streamlining preclinical pathways for a faster transition to First-in-Human trials
Download the case study to see how one biotech company saved $1M and shortened development timelines by 12 months with Thermo Fisher Scientific’s integrated CDMO and CRO solutions.

Added Date:

2025-06-26

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • June
Capability
  • Clinical trial solutions
Year
  • 2025
Language
  • Korean
Asset Type
  • Case study
Country
  • Korea
Region
  • Asia Pacific (APAC)
Content Category
  • Collateral
Market Category
  • Integrated offering

Country Availability:


()

Gated Form:

None Set